168 related articles for article (PubMed ID: 20960270)
1. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.
Enjuanes A; Ruiz-Gaspà S; Peris P; Ozalla D; Alvarez L; Combalia A; Martínez de Osaba MJ; Monegal A; Pares A; Guañabens N
Endocrine; 2010 Apr; 37(2):322-8. PubMed ID: 20960270
[TBL] [Abstract][Full Text] [Related]
2. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.
Enjuanes A; Ruiz-Gaspà S; Peris P; Ozalla D; Álvarez L; Combalia A; Martínez de Osaba MJ; Monegal A; Pares A; Guañabens N
Endocrine; 2010 Feb; 37(1):180-6. PubMed ID: 20963568
[TBL] [Abstract][Full Text] [Related]
3. Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis.
Giner M; Rios MJ; Montoya MJ; Vázquez MA; Miranda C; Pérez-Cano R
Eur J Pharmacol; 2011 Jan; 650(2-3):682-7. PubMed ID: 21050847
[TBL] [Abstract][Full Text] [Related]
4. Differences in otosclerotic and normal human stapedial osteoblast properties are normalized by alendronate in vitro.
Gronowicz G; Richardson YL; Flynn J; Kveton J; Eisen M; Leonard G; Aronow M; Rodner C; Parham K
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):657-66. PubMed ID: 25085325
[TBL] [Abstract][Full Text] [Related]
5. [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts].
Dong W; Qi M; Deng J; Chen H; Feng X; Liao N
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1695-8. PubMed ID: 23268391
[TBL] [Abstract][Full Text] [Related]
6. Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis.
Reyes-García R; Muñoz-Torres M; García DF; Mezquita-Raya P; García Salcedo JA; de Dios Luna J
Menopause; 2010; 17(1):140-4. PubMed ID: 19574937
[TBL] [Abstract][Full Text] [Related]
7. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
Viereck V; Gründker C; Friess SC; Frosch KH; Raddatz D; Schoppet M; Nisslein T; Emons G; Hofbauer LC
J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene.
Cheung J; Mak YT; Papaioannou S; Evans BA; Fogelman I; Hampson G
J Endocrinol; 2003 Jun; 177(3):423-33. PubMed ID: 12773123
[TBL] [Abstract][Full Text] [Related]
9. Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study.
Tat SK; Pelletier JP; Vergés J; Lajeunesse D; Montell E; Fahmi H; Lavigne M; Martel-Pelletier J
Arthritis Res Ther; 2007; 9(6):R117. PubMed ID: 17996099
[TBL] [Abstract][Full Text] [Related]
10. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
11. Osteoblasts play key roles in the mechanisms of action of strontium ranelate.
Brennan TC; Rybchyn MS; Green W; Atwa S; Conigrave AD; Mason RS
Br J Pharmacol; 2009 Aug; 157(7):1291-300. PubMed ID: 19563530
[TBL] [Abstract][Full Text] [Related]
12. Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro.
Koch FP; Merkel C; Ziebart T; Smeets R; Walter C; Al-Nawas B
Clin Oral Investig; 2012 Feb; 16(1):79-86. PubMed ID: 20938793
[TBL] [Abstract][Full Text] [Related]
13. Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts.
Jurado S; Garcia-Giralt N; Díez-Pérez A; Esbrit P; Yoskovitz G; Agueda L; Urreizti R; Pérez-Edo L; Saló G; Mellibovsky L; Balcells S; Grinberg D; Nogués X
J Cell Biochem; 2010 May; 110(2):304-10. PubMed ID: 20225238
[TBL] [Abstract][Full Text] [Related]
14. Alendronate stimulates osteoprotegerin expression in fibroblasts from periprosthetic membrane.
Qian Y; Zhang XL; Jiang Y; Zeng BF; Wang Q; Chen Y; Shen H; Wang Q
Hip Int; 2015; 25(6):581-4. PubMed ID: 26351115
[TBL] [Abstract][Full Text] [Related]
15. Osteogenic differentiation of periodontal fibroblasts is dependent on the strength of mechanical strain.
Jacobs C; Grimm S; Ziebart T; Walter C; Wehrbein H
Arch Oral Biol; 2013 Jul; 58(7):896-904. PubMed ID: 23422327
[TBL] [Abstract][Full Text] [Related]
16. Effect of compressive loading and incubation with clodronate on the RANKL/OPG system of human osteoblasts.
Grimm S; Walter C; Pabst A; Goldschmitt J; Wehrbein H; Jacobs C
J Orofac Orthop; 2015 Nov; 76(6):531-42. PubMed ID: 26446504
[TBL] [Abstract][Full Text] [Related]
17. Changes of serum soluble receptor activator for nuclear factor-κB ligand after glucocorticoid therapy reflect regulation of its expression by osteoblasts.
Kaneko K; Kusunoki N; Hasunuma T; Kawai S
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1909-17. PubMed ID: 22791764
[TBL] [Abstract][Full Text] [Related]
18. RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis.
Giner M; Rios MA; Montoya MA; Vázquez MA; Naji L; Pérez-Cano R
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):46-51. PubMed ID: 19073256
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates Reduce Smoking-Induced Osteoporotic-Like Alterations by Regulating RANKL/OPG in an Osteoblast and Osteoclast Co-Culture Model.
Zhu S; Häussling V; Aspera-Werz RH; Chen T; Braun B; Weng W; Histing T; Nussler AK
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374546
[TBL] [Abstract][Full Text] [Related]
20. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
